Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines. (Q30371054)

21 June 2017

1 reference

title

Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines. (English)

1 reference

21 June 2017

Jürgen Stech

0 references

author name string

Jürgen Stech

series ordinal

1 reference

21 June 2017

publication date

1 August 2008

1 reference

Expert Review of Vaccines

21 June 2017

published in

1 reference

21 June 2017

1 reference

21 June 2017

1 reference

21 June 2017

page(s)

739-743

1 reference

Requiring influenza vaccination for health care workers: seven truths we must accept

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Adaptation and Growth Characteristics of Influenza Virus at 25° C

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Toxicological evaluation of live attenuated, cold-adapted H5N1 vaccines in ferrets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Type 1 interferons and the virus-host relationship: a lesson in détente .

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Multiple anti-interferon actions of the influenza A virus NS1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Attenuation of equine influenza viruses through truncations of the NS1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Ab and T cell epitopes of influenza A virus, knowledge and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Host cell proteases controlling virus pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Activation of influenza A viruses by trypsin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

A DNA transfection system for generation of influenza A virus from eight plasmids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Generation of influenza A viruses entirely from cloned cDNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

Pathogenicity of influenza A/Seal/Mass/1/80 virus mutants for mammalian species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

The potential of a protease activation mutant of a highly pathogenic avian influenza virus for a pandemic live vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.739

21 January 2018

Identifiers

DOI

10.1586/14760584.7.6.739

1 reference

21 June 2017

1 reference